Phoenix, software for pharmacokinetic, pharmacodynamic and toxicokinetic modeling and simulation, is used by 6,000 researchers at 1,500 biopharmaceutical companies and 200 academic institutions in 60 countries, according to a news release.
The news release states that Phoenix Centers of Excellence routinely publish their work so researchers can benefit from their progress. They also serve as an informal scientific advisory group.
At PUMC Hospital, Professor Pei Hu, MD, professor and director of its Clinical Pharmacology Research Center, will use Certara’s modeling and simulation technology for first-in-human, point-of-care and late-phase clinical trials, according to a news release. Certara also has ongoing collaborations with pharmacometrics leaders in Japan. Professor Yusuke Tanigawara, PhD, is professor of clinical pharmacokinetics and pharmacodynamics at Keio University School of Medicine.
Certara’s other Phoenix Centers of Excellence are located at the University of Auckland School of Medicine; the State University of New York Buffalo School of Pharmacy and Pharmaceutical Sciences; the University of Minnesota School of Pharmacy; the University of North Carolina at Chapel Hill Eshelman School of Pharmacy; the University of Maryland School of Pharmacy; and the Kansas State University College of Veterinary Medicine.
More articles on health IT:
Hays Medical Center upgrades to MEDITECH’s web-based EHR
Dapasoft launches clinical data integration engine Corolar Cloud
AHA launches MACRA implementation tool
At the Becker's 11th Annual IT + Revenue Cycle Conference: The Future of AI & Digital Health, taking place September 14–17 in Chicago, healthcare executives and digital leaders from across the country will come together to explore how AI, interoperability, cybersecurity, and revenue cycle innovation are transforming care delivery, strengthening financial performance, and driving the next era of digital health. Apply for complimentary registration now.